Premium
The current biology of resistin
Author(s) -
Steppan Claire M.,
Lazar Mitchell A.
Publication year - 2004
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.2004.01306.x
Subject(s) - resistin , insulin resistance , obesity , medicine , adipocyte , endocrinology , diabetes mellitus , type 2 diabetes , insulin , metabolic syndrome , adipose tissue , type 2 diabetes mellitus , glucose homeostasis , hormone , pathogenesis , adiponectin
. Obesity and noninsulin‐dependent diabetes mellitus are globally epidemic. Insulin resistance is a major contributor to the pathogenesis of type II diabetes and plays a role in numerous other metabolic disorders including hypertension, dyslipidaemia and atherosclerosis. Obesity, in particular visceral adiposity, is positively correlated with insulin resistance. Although this correlation between adiposity and insulin resistance is well established in human beings as well as in rodent models, the mechanisms involved in obesity‐related insulin resistance are not fully defined. One mechanism is that factors secreted from adipocytes can affect peripheral insulin resistance. One candidate for such a factor is resistin, an adipocyte‐secreted hormone that impairs glucose homeostasis and insulin action in the mouse. This review will summarize our current understanding of resistin and will attempt to provide a framework for future study of its role in rodent and human physiology.